INS and metabolic dysfunction-associated steatotic liver disease: It ameliorates free fatty acid-induced hepatic steatosis and regulates the secretion of insulin, as well as significantly decreased lipid accumulation that leads to non-alcoholic fatty liver disease (NAFLD).